Table 1. Baseline Characteristics.
Age, years | 69 ± 11 |
Men, n (%) | 13 (46%) |
Body mass index (kg/m2) | 24.2 ± 3.6 |
Diabetes mellitus, n (%) | 3 (17%) |
Dyslipidemia, n (%) | 12 (43%) |
Chronic kidney disease, n (%) | 5 (18%) |
History of coronary artery disease, n (%) | 2 (7%) |
History of cerebrovascular disease, n (%) | 2 (7%) |
Current smoker, n (%) | 1 (4%) |
Angiotensin receptor blockers before enrollment | |
Candesartan 4 mg, n (%) | 19 (67%) |
Losartan 50 mg, n (%) | 1 (4%) |
Olmesartan 20 mg, n (%) | 6 (21%) |
Valsartan 80 mg, n (%) | 1 (4%) |
Telmisartan 40 mg, n (%) | 1 (4%) |
Concomitant medications | |
Calcium channel blockers, n (%) | 11 (39%) |
Diuretics, n (%) | 2 (7%) |
Beta blockers, n (%) | 5 (18%) |
Data are expressed as mean ± standard deviation or number (%).